To the full analysis
ASP Isotopes stock: growth
ASPIASP Isotopes reported $23.85M in revenue for fiscal 2025, up 475.5% on the prior year.
Revenue (Annual rate)
1.1%
per year from 2019 to 2025, per share −15.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2019 | |
|---|---|
| Revenue | 1.1% |
| Revenue per share | −15.3% |
| Earnings | no data |
| Earnings per share | no data |
| Free cash flow | no data |
| Free cash flow per share | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2019 | $22.63M | −$10.26M | $0 |
| 2021 | $0 | −$2.61M | −$3.57M |
| 2022 | $0 | −$4.95M | −$7.41M |
| 2023 | $433.03K | −$16.29M | −$7.74M |
| 2024 | $4.14M | −$32.33M | −$28.07M |
| 2025 | $23.85M | −$175.09M | −$47.43M |
Data status and sources
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Nov 2023)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.